BlueReg Group
BlueReg Group is a Paris-based pharmaceutical consulting firm (founded 2011, 101–250 employees) specializing in regulatory affairs, drug development, economic affairs, quality, and pharmacovigilance services for pharma and biotech clients.
- Company typePrivate
- Founded2011
- HeadquartersParis, France
- Headcount101–250
- GTM typeB2B
- OfferingServices
What BlueReg Group does
BlueReg Group is a private, Paris-headquartered consulting firm founded in 2011 that delivers specialized services to the pharmaceutical industry across five core practice areas: development, regulatory affairs, economic affairs, quality, and pharmacovigilance. With a headcount of 101–250 employees, the firm operates as a mid-size European regulatory and drug development consultancy, serving clients that require expert navigation of EMA/FDA-grade regulatory processes, market access strategy, health economics, and product safety monitoring.
The firm's service portfolio maps to the full pharmaceutical product lifecycle — from clinical development and submissions through post-approval maintenance, pharmacovigilance operations (including QPPV services, signal detection, and adverse event processing), health economics and outcomes research, and quality/compliance management. The combined PharmaLex-aligned content bundled into the input suggests BlueReg may operate within or adjacent to the broader Cencora/PharmaLex ecosystem, though this relationship is not explicitly confirmed in any BlueReg-attributed statement in the data.
Business model mechanics are not disclosed in the source material. As a specialized consulting firm with 101–250 employees, the implied model is a hybrid of project-based regulatory submissions, retained pharmacovigilance/FTE contracts, and advisory engagements priced on a time-and-materials or milestone basis — typical of mid-market European pharma consultancies. No pricing details, GTM motion descriptors, named customers, or revenue figures are provided in the input.
BlueReg Group firmographics
Firmographics- Name
- BlueReg Group
- Website
- https://blue-reg.com
- Company type
- Private
- Founded year
- 2011
- Headcount range
- 101–250 employees
- Short description
- BlueReg Group is a Paris-based pharmaceutical consulting firm (founded 2011, 101–250 employees) specializing in regulatory affairs, drug development, economic affairs, quality, and pharmacovigilance services for pharma and biotech clients.
- Ownership category
- akta.pro rank
BlueReg Group industry classification
Industry- Product category
- Pharmaceutical Regulatory Consulting
- NAICS
- Management Consulting Services (54161)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- GxP Audits & Supplier Qualification (GMP/GCP/GLP/GDP) (HLAGAKAE)
Keywords
Where BlueReg Group is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Markets served
BlueReg Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
BlueReg Group product offering
Product offeringCore offering
BlueReg Group is a consulting firm that provides specialized services in pharmaceutical development, regulatory affairs, economic affairs, quality, and pharmacovigilance. The company serves pharmaceutical, biotechnology, and medical device industry clients with consulting support across the product lifecycle, from development through post-market activities.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Development Consulting
Companies that use BlueReg Group
Customer profileIdeal customer profiles1 record
BlueReg Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BlueReg Group partnerships and signals
Strategic signalExpansion highlights2 records
BlueReg Group competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: Global testing and life sciences services group with regulatory and pharma product testing capabilities, including GMP/GLP compliance services that intersect with BlueReg's quality offering.
- IQVIA: Largest global CRO offering regulatory affairs and pharmacovigilance services as part of a full clinical and commercial platform; competes with BlueReg on bundled regulatory and R&D engagements.
- Parexel: Major global CRO with substantial regulatory consulting and pharmacovigilance practices; relevant as a broad competitor in regulatory affairs services for pharma and biotech sponsors.
- ICON plc: Global CRO (post-PRA Health Sciences) with dedicated regulatory and pharmacovigilance capabilities; competes with BlueReg on larger multi-functional programs requiring regulatory expertise.
- Charles River Laboratories: Global CRO/CDMO with a regulatory and quality consulting practice serving pharma and biotech; competes with BlueReg on regulatory affairs and quality compliance engagements.
- SGS Health Science: Global life sciences services division of SGS offering GxP audits, quality compliance, and regulatory consulting — directly comparable to BlueReg's quality and GxP audit work.
Emerging players
- Pharma Wizard: Specialized pharma regulatory and quality consulting firm with overlap in CMC, regulatory affairs, and pharmacovigilance services; comparable as a niche European-headquartered consultancy.
Direct peers
- Cencora PharmaLex: Cencora-owned specialized pharma services provider offering regulatory affairs, CMC, pharmacovigilance, and market access — directly overlapping BlueReg's core service lines of regulatory affairs, quality, and pharmacovigilance.
- NDA Group: European-based regulatory affairs and drug development consultancy serving pharma and biotech; comparable in size, geography, and service mix to BlueReg, particularly around submission strategy and health authority interactions.
- Voisin Consulting Life Sciences (VCLS): Paris-headquartered regulatory and health economics consultancy covering product development, regulatory affairs, and market access — a direct French-headquartered competitor with an overlapping service portfolio.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
BlueReg Group social profiles
Digital presenceBlueReg Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
BlueReg Group leadership team
Management profileNumber of profiles
BlueReg Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BlueReg Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BlueReg Group
What does BlueReg Group do?
BlueReg Group is a consulting firm that provides specialized services in pharmaceutical development, regulatory affairs, economic affairs, quality, and pharmacovigilance. The company serves pharmaceutical, biotechnology, and medical device industry clients with consulting support across the product lifecycle, from development through post-market activities.
When was BlueReg Group founded?
BlueReg Group was founded in 2011. It employs 101 to 250 people.
Where is BlueReg Group based?
BlueReg Group is headquartered in Paris, France, in the Europe region.
Who are BlueReg Group's main competitors?
Broad incumbents on record are Eurofins Scientific, IQVIA, Parexel, ICON plc, Charles River Laboratories and SGS Health Science. Pharma Wizard is listed as an emerging player. Direct peers are Cencora PharmaLex, NDA Group and Voisin Consulting Life Sciences (VCLS).
Does BlueReg Group have an API?
No public API is recorded for BlueReg Group.
What industry is BlueReg Group in?
BlueReg Group's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is HLAGAKAE, GxP Audits & Supplier Qualification (GMP/GCP/GLP/GDP). Its NAICS code is 54161 and its SIC code is 8742.